Exelixis (EXEL) Deferred Taxes (2018 - 2022)
Exelixis' (EXEL) quarterly Deferred Taxes came in at $60.4 million in Q4 2022, up 526.14% year-on-year from $9.6 million in Q4 2021, and up 294.03% quarter-over-quarter from $15.3 million in Q3 2022.
Exelixis (EXEL) Deferred Taxes (2018 - 2022) Analysis & Trends
Exelixis' Deferred Taxes history runs 5 years deep, the most recent figure standing at $60.4 million for Q4 2022.
- On a quarterly basis, Deferred Taxes rose 526.14% year-over-year to $60.4 million in Q4 2022; TTM through Mar 2023 was $75.7 million, a 216.01% increase from a year earlier, with the FY2026 full-year figure at -$126.2 million, down 312.31% from the prior year.
- Deferred Taxes grew to $60.4 million in Q4 2022 per EXEL's latest filing, from $15.3 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $244.1 million in Q4 2018 and bottomed at -$71.6 million in Q1 2021.
- The 5-year median for Deferred Taxes is -$3.1 million (2021), against an average of $19.4 million.
- Biggest YoY gain for Deferred Taxes was 526.14% in 2022; the steepest drop was 552.13% in 2022.
- Year by year, Deferred Taxes stood at $244.1 million in 2018, then slumped by 90.47% to $23.3 million in 2019, then sank by 143.52% to -$10.1 million in 2020, then plunged by 39.85% to -$14.2 million in 2021, then jumped by 526.14% to $60.4 million in 2022.
- Per Business Quant, the three latest EXEL Deferred Taxes figures stand at $60.4 million (Q4 2022), $15.3 million (Q3 2022), and -$15.3 million (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2022 | 60.36 Mn |
| Jul 1, 2022 | 15.32 Mn |
| Apr 1, 2022 | -15.32 Mn |
| Dec 31, 2021 | -14.16 Mn |
| Oct 1, 2021 | -9.57 Mn |
| Jul 2, 2021 | -26.19 Mn |
| Apr 2, 2021 | 3.39 Mn |
| Jan 1, 2021 | -71.60 Mn |
| Apr 3, 2020 | -10.13 Mn |
| Sep 27, 2019 | 23.27 Mn |
| Jun 28, 2019 | 33.07 Mn |
| Dec 28, 2018 | 244.11 Mn |